Showing 1 - 20 results of 52 for search '"Renal"', query time: 0.10s Refine Results
  1. 1

    Perioperative, functional, and oncological outcomes of robotic vs. laparoscopic partial nephrectomy for complex renal tumors (RENAL score ≥7): an evidence-based analysis by Li Wang, Jing-ya Deng, Cai Liang, Ping-yu Zhu

    Published 2023-06-01
    “…ObjectiveTo evaluate the current literature comparing outcomes of robotic partial nephrectomy (RPN) versus laparoscopic partial nephrectomy (LPN) treating complex renal tumors (RENAL nephrometry score ≥7).MethodsWe systematically searched the Cochrane Library, PubMed, Google Scholar, EMBASE, and Scopus databases up to March 2023. …”
    Get full text
    Article
  2. 2

    Intermittent hilar occlusion attenuates or prevents renal ischaemia-reperfusion in mice by Lei Wang, Cheng Peng, Jianwen Chen, Huaikang Li, Qilong Jiao, Zhou Zhang, Li Wang, Qing Yuan, Baojun Wang, Yan Huang, Xin Ma

    Published 2022-09-01
    “…Background: A minimal decrease in renal function in partial nephrectomy is an important clinical and experimental research objective. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Cell-Free Hemoglobin in Acute Kidney Injury after Lung Transplantation and Experimental Renal Ischemia/Reperfusion by Robert Greite, Li Wang, Lukas Gohlke, Sebastian Schott, Kirill Kreimann, Julian Doricic, Andreas Leffler, Igor Tudorache, Jawad Salman, Ruslan Natanov, Fabio Ius, Christine Fegbeutel, Axel Haverich, Ralf Lichtinghagen, Rongjun Chen, Song Rong, Hermann Haller, Vijith Vijayan, Magnus Gram, Irina Scheffner, Faikah Gueler, Wilfried Gwinner, Stephan Immenschuh

    Published 2022-10-01
    “…Because multiple other factors can contribute to AKI development in the complex clinical setting of LuTx, we next investigated the role of exogenous CFH administration in a mouse model of mild bilateral renal ischemia reperfusion injury (IRI). Exogenous administration of CFH after reperfusion caused overt AKI with creatinine increase, tubular injury, and enhanced markers of renal inflammation compared with vehicle-treated animals. …”
    Get full text
    Article
  8. 8

    Protocol and statistical analysis plan for the Antibiotic Choice On ReNal outcomes (ACORN) randomised clinical trial by Sunil Kripalani, Li Wang, Ruth Kleinpell, Wesley H Self, Todd W Rice, Matthew W Semler, Edward D Siew, Paul Harris, Jonathan D Casey, Adam Wright, Tina Hartert, Gordon Bernard, Joanna Stollings, Russell Rothman, Jay Morrison, Christopher Lindsell, Todd Rice, Robert Freundlich, Edward Tang Qian, Justin Siemann, Mary Lynn Dear, Bradley Daniel Lloyd, Kevin Seitz, George Nelson, Patty Wright, Bradley Dennis, Jesse Wrenn, Jonathan Andereck, Bob Dittus, Shon Dwyer, Cheryl Gatto, Frank Harrell, Jim Hayman, Catherine Ivory, Lee Ann Liska, Patrick Luther, Thomas Nantais, Jill Pulley, Kris Rehm, Matt Semler, Robin Steaban, Philip Walker, Consuelo Wilkins, Autumn Zuckerman

    Published 2023-03-01
    “…This manuscript describes the protocol and analysis plan for a trial designed to compare the effects of antipseudomonal cephalosporins and antipseudomonal penicillins among acutely ill patients receiving empiric antibiotics.Methods and analysis The Antibiotic Choice On ReNal outcomes trial is a prospective, single-centre, non-blinded randomised trial being conducted at Vanderbilt University Medical Center. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11

    Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury by Shanshan Zou, Jianing Chen, Peihui Zhou, Mengzhu Xue, Ming Wu, Li Wang

    Published 2024-02-01
    “…Inhibition of the methyltransferase Enhancer of Zeste Homolog 2 (EZH2) by its inhibitor 3-DZNeP (3-Deazaneplanocin A) exerts renal benefits in acute renal ischemia-reperfusion injury (IRI). …”
    Get full text
    Article
  12. 12

    Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014. by Tao Bai, Li Wang, Dongwen Wang, Xiaobin Yuan, Wei Bai, Qin Yang, Xian Yang

    Published 2015-01-01
    “…RCC is the most common solid renal malignancy in adults worldwide. To provide the insight of clinicopathologica epidemiological characteristics and change tendencies of renal cell carcinoma (RCC), 2154 cases were collected from Shanxi Province of China, including diagnose time, age, gender, tumor size, Fuhrman grade, tumor stage, tumor location, local advance or distant metastasis and first symptom from 2005 to 2014. …”
    Get full text
    Article
  13. 13

    Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease by Pan Zhang, Xifan Wang, Shenghui Li, Xuesen Cao, Jianzhou Zou, Yi Fang, Yiqin Shi, Fangfang Xiang, Bo Shen, Yixuan Li, Bing Fang, Yue Zhang, Ruochun Guo, Qingbo Lv, Liwen Zhang, Yufei Lu, Yaqiong Wang, Jinbo Yu, Yeqing Xie, Ran Wang, Xiaohong Chen, Jiawei Yu, Zhen Zhang, Jingjing He, Jing Zhan, Wenlv Lv, Yuxin Nie, Jieru Cai, Xialian Xu, Jiachang Hu, Qi Zhang, Ting Gao, Xiaotian Jiang, Xiao Tan, Ning Xue, Yimei Wang, Yimei Ren, Li Wang, Han Zhang, Yichun Ning, Jing Chen, Lin Zhang, Shi Jin, Fazheng Ren, Stanislav Dusko Ehrlich, Liang Zhao, Xiaoqiang Ding

    Published 2023-10-01
    “…Abstract Background The gut microbiota plays a crucial role in regulating host metabolism and producing uremic toxins in patients with end-stage renal disease (ESRD). Our objective is to advance toward a holistic understanding of the gut ecosystem and its functional capacity in such patients, which is still lacking. …”
    Get full text
    Article
  14. 14
  15. 15

    New-onset metabolic syndrome is associated with accelerated renal function decline partially through elevated uric acid: an epidemiological cohort study by Qiuyu Xu, Qiuyu Xu, Xiaohong Fan, Gang Chen, Jie Ma, Wenling Ye, Sanxi Ai, Li Wang, Ke Zheng, Yan Qin, Limeng Chen, Mingxi Li, Xuemei Li

    Published 2024-02-01
    “…Multivariate logistic regression and stratification analysis evaluated the relationship between clinical factors and renal function decline under different MetS statuses. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials by Zhi Wen, Li Wang, Jing Huang, Yang Liu, Cai-xia Chen, Chong-jian Wang, Lin-lin Chen, Xue-song Yang

    Published 2023-06-01
    “…ObjectivesThe perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. …”
    Get full text
    Article